Driving faster innovation, greater productivity and transformative patient outcomes
R&D Solutions
Capabilities
Helping biopharma companies focus on the patient
A Life Sciences industry leader
New Science is driving biopharma growth
54%
of sales between 2017 and 2022 are expected to be driven by New Science, up from 47% between 2012 and 2017.
6-7x
more investment is being made in digital, data and genomics by leaders in New Science compared to their peers.
50%
higher Probability of Technical and Regulatory Success (PTRS) with New Science compared to other treatments.